Stress, inflammatory markers and factors associated in patients with type 2 diabetes mellitus

被引:7
|
作者
Aguilar-Zavala, Herlinda [1 ]
Garay-Sevilla, Ma. Eugenia [1 ]
Malacara, Juan Manuel [1 ]
Perez-Luque, Elva Leticia [1 ]
机构
[1] Univ Guanajuato, Inst Invest Med, Guanajuato 37320, Mexico
关键词
type; 2; DM; stress; Hsp60; TNF-alpha; cortisol;
D O I
10.1002/smi.1162
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Stress is evaluated using tumour necrosis factor-alpha (TNF-alpha), Heat Shock Protein 60 (Hsp60) and other markers in chronic diseases. We examined the association of Hsp60, cortisol, TNF-alpha and interleukin-6 (IL-6) serum levels with psychological and socio-economic factors in patients with type 2 diabetes mellitus (DM-2). We studied 151 DM-2 patients in groups with <1 year and >5 years since diagnosis. Clinical data, family income and questionnaires of anxiety, depression, perceived stress, social support, glucose, glycated haemoglobin, lipids, Hsp60, cortisol, IL-6 and TNF-alpha were collected. Patients with >5 years since diagnosis of DM-2 had lower body mass index (p < 0.016), higher glucose (p < 0.005) and HbA(1c) (p < 0.005) levels. The group of recent diagnosis had higher Hsp60 (p < 0.00003). Hsp60 was associated negatively with years since diagnosis (p < 0.000012), and positively with glucose (p < 0.029). Cortisol was positively associated with glucose levels (p < 0.019) and family income (p < 0.037). TNF-alpha was associated with years since diagnosis (P < 0.004) and perceived stress (p < 0.018). At early stages of DM-2, Hsp60 increases with glucose levels, cortisol is associated with glucose levels. At later stages TNF-alpha increases, associated with perceived stress. Copyright (C) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 50 条
  • [41] ANGIOGENIC FACTORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Rosc, D.
    Drela, E.
    Kulwas, A.
    Jundzill, W.
    Ruszkowska-Ciastek, B.
    Stankowska, K.
    Goralczyk, B.
    THROMBOSIS RESEARCH, 2014, 133 : S96 - S96
  • [42] Risk factors in patients with type 2 diabetes mellitus
    Regla Carolino, Idalina Diair
    Molena-Fernandes, Carlos Alexandre
    Tasca, Raquel Soares
    Marcon, Sonia Silva
    Nakamura Cuman, Roberto Kenji
    REVISTA LATINO-AMERICANA DE ENFERMAGEM, 2008, 16 (02): : 238 - 244
  • [43] Association of Islet Amyloid Polypeptide and Inflammatory Markers in Type 2 Diabetes Mellitus
    Badade, Zunjarrao Ganpat
    Shinde, Yogita Mahendra
    Kaul, Shibban K.
    Rai, Sandeep
    Kadam, Sameer
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (06)
  • [44] Diabetes mellitus type 2 is associated with upregulation of atherogenic surface markers
    Niebauer, J
    Peschel, T
    Beitz, F
    Tarnok, A
    Schuler, G
    EUROPEAN HEART JOURNAL, 2001, 22 : 645 - 645
  • [45] Inflammatory markers and the risk of vascular complications and mortality in type 2 diabetes mellitus
    Hillis, G. S.
    Lowe, G.
    Woodward, M.
    Rumley, A.
    Harrap, S.
    Marre, M.
    Hamet, P.
    Patel, A.
    Poulter, N.
    Chalmers, J.
    EUROPEAN HEART JOURNAL, 2013, 34 : 962 - 962
  • [46] Insulin resistance, inflammatory markers and vascular function in type 2 diabetes mellitus
    Vigilance, J. E.
    Choo-Kang, E.
    Reid, H. L.
    Wright Pascoe, R.
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 : 29 - 29
  • [47] Inflammatory markers response to crocin supplementation in patients with type 2 diabetes mellitus: A randomized controlled trial
    Behrouz, Vahideh
    Sohrab, Golbon
    Hedayati, Mehdi
    Sedaghat, Meghdad
    PHYTOTHERAPY RESEARCH, 2021, 35 (07) : 4022 - 4031
  • [48] FEATURES OF ATHEROGENIC LIPID PROFILE AND INFLAMMATORY MARKERS IN PATIENTS WITH STABLE ANGINA AND TYPE 2 DIABETES MELLITUS
    Petelina, Tatiana
    Musikhina, Natalia
    Gapon, Ludmila
    Emeneva, Irina
    Gorbatenko, Elena
    ATHEROSCLEROSIS, 2017, 263 : E118 - E118
  • [49] Cilostazol reduces inflammatory burden and oxidative stress in hypertensive type 2 diabetes mellitus patients
    Agrawal, Neeraj K.
    Maiti, Rituparna
    Dash, D.
    Pandey, B. L.
    PHARMACOLOGICAL RESEARCH, 2007, 56 (02) : 118 - 123
  • [50] Inflammatory markers and Type 2 diabetes mellitus as prognostic risk factors in low-risk bladder cancer
    Frego, Nicola
    Contieri, Roberto
    Diana, Pietro
    Mancon, Stefano
    Colombo, Piergiuseppe
    Lazzeri, Massimo
    Buffi, Nicolo Maria
    Casale, Paolo
    Hurle, Rodolfo
    BJU INTERNATIONAL, 2023, 132 (02) : 154 - 156